Hypoglycaemia revealing heterozygous insulin receptor mutations. - Inserm - Institut national de la santé et de la recherche médicale Accéder directement au contenu
Article Dans Une Revue Diabetes & Metabolism Année : 2017

Hypoglycaemia revealing heterozygous insulin receptor mutations.

Résumé

Major hyperinsulinemia, acanthosis nigricans, impaired glucose tolerance and ovarian hyperandrogenism characterize Type A insulin resistance (IR) syndrome due to dominant-negative heterozygous mutations in the insulin receptor gene (INSR). However, two unrelated families have been described with symptomatic hypoglycemia due to heterozygous INSR p.Arg1201 substitutions in the tyrosine kinase domain. In these patients, major hyperinsulinemia together with decreased insulin clearance was suggested to rescue genetically-altered insulin signalling in vivo in liver and/or muscle. We broaden the genetic spectrum of this rare phenotype of Type A insulin resistance by reporting the observations of two patients with INSR p.Met1180Val or p.Arg1201Gln heterozygous mutations revealed by repeated symptomatic hypoglycemia. Our observations further demonstrate that hyperinsulinemic hypoglycemia in adults can reveal different heterozygous mutations in the insulin receptor tyrosine kinase domain, whether associated or not with acanthosis nigricans, impaired glucose tolerance and/or ovarian hyperandrogenism.
Fichier principal
Vignette du fichier
Letter to the Editor Preumont et al.pdf (30.54 Ko) Télécharger le fichier
Origine : Fichiers produits par l'(les) auteur(s)
Loading...

Dates et versions

inserm-01369327 , version 1 (20-09-2016)

Identifiants

Citer

Vanessa Preumont, Christine Feincoeur, Olivier Lascols, Carine Courtillot, Philippe Touraine, et al.. Hypoglycaemia revealing heterozygous insulin receptor mutations.. Diabetes & Metabolism, 2017, 43 (1), pp.95-96. ⟨10.1016/j.diabet.2016.07.001⟩. ⟨inserm-01369327⟩
136 Consultations
216 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More